dorsaVi Limited ( (AU:DVL) ) has issued an announcement.
dorsaVi has launched a groundbreaking 3D motion analysis test designed to reduce ACL injuries in athletes. This innovative tool, which utilizes FDA-cleared wearable sensors and advanced AI, offers a significant improvement over traditional 1D force plates by capturing critical rotational torque forces. The new technology is expected to open substantial market opportunities in elite sports, rehabilitation centers, and physiotherapy clinics, enabling real-time, laboratory-grade analysis for proactive injury prevention and rehabilitation strategies.
More about dorsaVi Limited
dorsaVi Limited is a global leader in FDA-cleared wearable sensor technology and human movement analysis. The company focuses on providing advanced solutions for assessing human movement, particularly in the sports and healthcare industries.
YTD Price Performance: -16.67%
Average Trading Volume: 663,764
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$5.12M
For detailed information about DVL stock, go to TipRanks’ Stock Analysis page.